HEADER LYASE 03-AUG-15 5D0R TITLE CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH THE INHIBITOR TITLE 2 BITHIONOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 1-469; COMPND 5 SYNONYM: AH-RELATED PROTEIN,ADENYLATE CYCLASE HOMOLOG,GERM CELL COMPND 6 SOLUBLE ADENYLYL CYCLASE,SAC,TESTICULAR SOLUBLE ADENYLYL CYCLASE; COMPND 7 EC: 4.6.1.1; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: CYS255 MODIFIED BY BETA-MERCAPTOETHANOL SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADCY10, SAC; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PVL1392 KEYWDS LYASE EXPDTA X-RAY DIFFRACTION AUTHOR S.KLEINBOELTING,C.STEEGBORN REVDAT 6 23-OCT-24 5D0R 1 REMARK REVDAT 5 10-JAN-24 5D0R 1 REMARK REVDAT 4 27-MAR-19 5D0R 1 SOURCE ATOM REVDAT 3 11-MAY-16 5D0R 1 JRNL REVDAT 2 23-MAR-16 5D0R 1 JRNL REVDAT 1 16-MAR-16 5D0R 0 JRNL AUTH S.KLEINBOELTING,L.RAMOS-ESPIRITU,H.BUCK,L.COLIS, JRNL AUTH 2 J.VAN DEN HEUVEL,J.F.GLICKMAN,L.R.LEVIN,J.BUCK,C.STEEGBORN JRNL TITL BITHIONOL POTENTLY INHIBITS HUMAN SOLUBLE ADENYLYL CYCLASE JRNL TITL 2 THROUGH BINDING TO THE ALLOSTERIC ACTIVATOR SITE. JRNL REF J.BIOL.CHEM. V. 291 9776 2016 JRNL REFN ESSN 1083-351X JRNL PMID 26961873 JRNL DOI 10.1074/JBC.M115.708255 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0124 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 86.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 25668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1383 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.24 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1859 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 99 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3654 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.22000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : 0.70000 REMARK 3 B12 (A**2) : -0.11000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.256 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.177 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.431 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3817 ; 0.023 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3644 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5149 ; 2.177 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8377 ; 1.134 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 463 ; 7.642 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 171 ;35.296 ;24.444 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 646 ;16.216 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;15.617 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 569 ; 0.131 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4247 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 876 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1847 ; 2.402 ; 2.831 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1845 ; 2.397 ; 2.827 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2305 ; 3.946 ; 4.228 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 7 A 468 REMARK 3 ORIGIN FOR THE GROUP (A): 21.2234 25.3650 0.5942 REMARK 3 T TENSOR REMARK 3 T11: 0.0204 T22: 0.0439 REMARK 3 T33: 0.0125 T12: 0.0029 REMARK 3 T13: 0.0061 T23: -0.0017 REMARK 3 L TENSOR REMARK 3 L11: 0.4852 L22: 0.3561 REMARK 3 L33: 0.6702 L12: 0.0243 REMARK 3 L13: 0.0195 L23: -0.0493 REMARK 3 S TENSOR REMARK 3 S11: -0.0130 S12: -0.0264 S13: -0.0055 REMARK 3 S21: 0.0107 S22: -0.0035 S23: 0.0603 REMARK 3 S31: -0.0147 S32: -0.0922 S33: 0.0165 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5D0R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000212495. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : SI111-DCM WITH SAGITTAL BENDER REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27051 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 86.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.01380 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.08940 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4CLK REMARK 200 REMARK 200 REMARK: ROCKETS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI REMARK 280 -SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL, PH 6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.98900 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.98900 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.98900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 812 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 THR A 3 REMARK 465 PRO A 4 REMARK 465 LYS A 5 REMARK 465 GLU A 6 REMARK 465 PRO A 351 REMARK 465 VAL A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 THR A 132 OG1 CG2 REMARK 470 GLU A 137 CG CD OE1 OE2 REMARK 470 PHE A 350 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 353 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 ASN A 436 CG OD1 ND2 REMARK 470 LYS A 451 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 11 CB TRP A 11 CG -0.115 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 15 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 15 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP A 186 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 ASP A 186 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ASP A 258 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 278 CB - CG - OD2 ANGL. DEV. = -6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 10 43.39 -99.72 REMARK 500 SER A 49 -179.14 -68.28 REMARK 500 ALA A 97 114.81 -161.22 REMARK 500 THR A 132 48.65 73.23 REMARK 500 ASP A 159 -154.94 -120.63 REMARK 500 ASN A 185 3.46 83.89 REMARK 500 ASN A 247 3.37 -69.46 REMARK 500 ASP A 258 97.64 -166.39 REMARK 500 GLN A 329 43.59 71.25 REMARK 500 LYS A 451 109.13 -52.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 811 DISTANCE = 6.27 ANGSTROMS REMARK 525 HOH A 812 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH A 813 DISTANCE = 7.19 ANGSTROMS REMARK 525 HOH A 814 DISTANCE = 7.72 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B1T A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 509 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 510 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 511 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 512 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 513 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE (APO FORM) REMARK 900 RELATED ID: 4CLK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH REMARK 900 ALPHA,BETA-METHYLENEADENOSINE-5'-TRIPHOSPHATE REMARK 900 RELATED ID: 4CLL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH REMARK 900 BICARBONATE REMARK 900 RELATED ID: 4CLP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE COMPLEX WITH REMARK 900 ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE REMARK 900 RELATED ID: 4CLS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH REMARK 900 PYROPHOSPHATE REMARK 900 RELATED ID: 4CLT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH ADENOSINE- REMARK 900 3',5'-CYCLIC-MONOPHOSPHATE AND PPYROPHOSPHATE REMARK 900 RELATED ID: 4CLU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH REMARK 900 PYROPHOSPHATE REMARK 900 RELATED ID: 4CLW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH REMARK 900 ALPHA,BETA-METHYLENEADENOSINE-5'-TRIPHOSPHATE SOAKED WITH BISULFITE REMARK 900 RELATED ID: 4CLY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE SOAKED WITH REMARK 900 BISELENITE REMARK 900 RELATED ID: 4CLZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH INHIBITOR REMARK 900 4,4'-DIISOTHIOCYANO-2,2'-STILBENEDISULFONIC ACID REMARK 900 RELATED ID: 4CM2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE SOAKED WITH REMARK 900 BISULFITE DBREF 5D0R A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 5D0R HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 5D0R HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 5D0R HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 5D0R HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 5D0R HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 5D0R HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 5D0R CME A 253 CYS MODIFIED RESIDUE HET CME A 253 10 HET B1T A 501 19 HET ACT A 502 4 HET EDO A 503 4 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 4 HET EDO A 507 4 HET EDO A 508 4 HET DMS A 509 4 HET DMS A 510 4 HET DMS A 511 4 HET GOL A 512 6 HET GOL A 513 6 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM B1T 2,2'-SULFANEDIYLBIS(4,6-DICHLOROPHENOL) HETNAM ACT ACETATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM DMS DIMETHYL SULFOXIDE HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 B1T C12 H6 CL4 O2 S FORMUL 3 ACT C2 H3 O2 1- FORMUL 4 EDO 6(C2 H6 O2) FORMUL 10 DMS 3(C2 H6 O S) FORMUL 13 GOL 2(C3 H8 O3) FORMUL 15 HOH *214(H2 O) HELIX 1 AA1 TRP A 11 ALA A 18 1 8 HELIX 2 AA2 PRO A 21 TYR A 26 1 6 HELIX 3 AA3 PHE A 51 SER A 60 1 10 HELIX 4 AA4 ALA A 61 MET A 64 5 4 HELIX 5 AA5 ARG A 66 PHE A 89 1 24 HELIX 6 AA6 GLU A 108 LYS A 110 5 3 HELIX 7 AA7 GLN A 111 PHE A 130 1 20 HELIX 8 AA8 GLY A 169 ALA A 182 1 14 HELIX 9 AA9 SER A 190 CYS A 197 1 8 HELIX 10 AB1 ASN A 225 THR A 235 1 11 HELIX 11 AB2 SER A 242 LYS A 246 5 5 HELIX 12 AB3 ARG A 250 LEU A 255 5 6 HELIX 13 AB4 ASP A 258 LYS A 267 1 10 HELIX 14 AB5 MET A 270 ASP A 278 1 9 HELIX 15 AB6 LYS A 306 GLN A 329 1 24 HELIX 16 AB7 ASP A 357 SER A 374 1 18 HELIX 17 AB8 GLY A 408 TYR A 421 1 14 HELIX 18 AB9 ASP A 428 GLY A 434 1 7 HELIX 19 AC1 PRO A 438 TYR A 440 5 3 SHEET 1 AA1 5 ASP A 92 ALA A 97 0 SHEET 2 AA1 5 ALA A 100 ARG A 106 -1 O LEU A 104 N ASP A 92 SHEET 3 AA1 5 PHE A 35 ILE A 48 -1 N MET A 44 O ALA A 103 SHEET 4 AA1 5 VAL A 143 GLY A 158 -1 O VAL A 156 N PHE A 35 SHEET 5 AA1 5 SER A 163 ILE A 168 -1 O HIS A 164 N PHE A 157 SHEET 1 AA2 7 ASP A 92 ALA A 97 0 SHEET 2 AA2 7 ALA A 100 ARG A 106 -1 O LEU A 104 N ASP A 92 SHEET 3 AA2 7 PHE A 35 ILE A 48 -1 N MET A 44 O ALA A 103 SHEET 4 AA2 7 VAL A 143 GLY A 158 -1 O VAL A 156 N PHE A 35 SHEET 5 AA2 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AA2 7 GLN A 210 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AA2 7 ILE A 202 VAL A 207 -1 N GLU A 205 O LYS A 214 SHEET 1 AA3 5 GLN A 331 MET A 337 0 SHEET 2 AA3 5 CYS A 342 PHE A 348 -1 O LEU A 345 N LYS A 334 SHEET 3 AA3 5 GLU A 288 PHE A 301 -1 N VAL A 295 O CYS A 346 SHEET 4 AA3 5 ILE A 379 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA3 5 ARG A 401 ILE A 407 -1 O ARG A 401 N HIS A 398 SHEET 1 AA4 7 GLN A 331 MET A 337 0 SHEET 2 AA4 7 CYS A 342 PHE A 348 -1 O LEU A 345 N LYS A 334 SHEET 3 AA4 7 GLU A 288 PHE A 301 -1 N VAL A 295 O CYS A 346 SHEET 4 AA4 7 ILE A 379 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA4 7 VAL A 425 CYS A 427 1 O THR A 426 N ILE A 384 SHEET 6 AA4 7 TYR A 460 TYR A 462 -1 O TYR A 462 N VAL A 425 SHEET 7 AA4 7 PHE A 442 GLU A 444 -1 N LYS A 443 O GLN A 461 LINK C ALA A 252 N CME A 253 1555 1555 1.33 LINK C CME A 253 N THR A 254 1555 1555 1.34 CISPEP 1 ARG A 33 PRO A 34 0 -1.55 SITE 1 AC1 12 PHE A 45 LYS A 95 ALA A 97 ALA A 100 SITE 2 AC1 12 LEU A 102 VAL A 172 VAL A 175 ARG A 176 SITE 3 AC1 12 PHE A 336 MET A 337 PHE A 338 ACT A 502 SITE 1 AC2 4 PHE A 338 ASN A 412 B1T A 501 HOH A 682 SITE 1 AC3 4 SER A 80 HIS A 398 THR A 399 HOH A 640 SITE 1 AC4 4 THR A 55 ILE A 390 PHE A 392 GLN A 409 SITE 1 AC5 3 HIS A 162 LYS A 267 TYR A 268 SITE 1 AC6 7 PHE A 39 ASP A 40 ARG A 106 VAL A 107 SITE 2 AC6 7 GLU A 108 LYS A 468 HOH A 622 SITE 1 AC7 7 TRP A 194 ARG A 199 ILE A 202 GLU A 203 SITE 2 AC7 7 ILE A 204 ILE A 327 HOH A 609 SITE 1 AC8 5 TYR A 240 PRO A 241 LYS A 246 HOH A 638 SITE 2 AC8 5 HOH A 677 SITE 1 AC9 4 TYR A 77 HIS A 78 LEU A 129 GLN A 133 SITE 1 AD1 7 ILE A 24 GLY A 27 HIS A 28 PHE A 29 SITE 2 AD1 7 SER A 264 TYR A 268 HOH A 753 SITE 1 AD2 4 THR A 322 GLN A 331 ILE A 332 HOH A 673 SITE 1 AD3 8 MET A 64 THR A 161 HIS A 162 GLN A 266 SITE 2 AD3 8 LYS A 267 VAL A 269 GLU A 271 HOH A 603 SITE 1 AD4 6 ASP A 22 LEU A 23 ASP A 92 LEU A 104 SITE 2 AD4 6 ARG A 106 TYR A 239 CRYST1 99.403 99.403 99.978 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010060 0.005808 0.000000 0.00000 SCALE2 0.000000 0.011616 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010002 0.00000